Trupanion, Inc. <TRUP.O>: Piper Sandler cuts to neutral from overweight; cuts target price to $32 from $45
TRUP•Related News
Nasdaq trade halt continues <SVA.O> reason not available at 03:58 AM
SVA•
Nxera Pharma Co., Ltd.- Nxera Pharma's Partner Neurocrine Biosciences Receives IND Acceptance From FDA For Phase 2 Study Of NBI-1117567 For Alzheimer's Cognition
NBIX•
Nasdaq trade halt continues <LAWR.O> reason not available at 03:58 AM
LAWR•
Nxera Pharma says Neurocrine wins FDA IND clearance for Phase 2 Alzheimer’s cognition trial of NBI-1117567
NBIX•
Chinese exports help ease the pain for London zinc shorts: Andy Home
XLB•